BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:21 PM
 | 
Mar 20, 2007
 |  BC Extra  |  Company News

InterMune cuts headcount, withdraws guidance

ITMN said it plans to reduce headcount by 50% to 115 this year, with the cuts primarily in the clinical, regulatory, medical affairs and commercial areas. The announcement came two weeks after ITMN said it would discontinue development of Actimmune for idiopathic pulmonary fibrosis (IPF) after data from a Phase III trial...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >